2 false false false false false false false false false false true false false false false false false No description of principal activity 2024-04-01 Sage Accounts Production Advanced 2023 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 11217596 2024-04-01 2025-03-31 11217596 2025-03-31 11217596 2024-03-31 11217596 2023-04-01 2024-03-31 11217596 2024-03-31 11217596 2023-03-31 11217596 bus:OrdinaryShareClass1 2024-04-01 2025-03-31 11217596 bus:Director1 2024-04-01 2025-03-31 11217596 core:WithinOneYear 2025-03-31 11217596 core:WithinOneYear 2024-03-31 11217596 core:MotorVehicles 2024-03-31 11217596 core:MotorVehicles 2025-03-31 11217596 core:MotorVehicles 2024-04-01 2025-03-31 11217596 core:AfterOneYear 2025-03-31 11217596 core:AfterOneYear 2024-03-31 11217596 core:ShareCapital 2025-03-31 11217596 core:ShareCapital 2024-03-31 11217596 core:RetainedEarningsAccumulatedLosses 2025-03-31 11217596 core:RetainedEarningsAccumulatedLosses 2024-03-31 11217596 core:MotorVehicles 2024-03-31 11217596 core:LeasedAssetsHeldAsLessee core:MotorVehicles 2025-03-31 11217596 core:LeasedAssetsHeldAsLessee core:MotorVehicles 2024-03-31 11217596 bus:SmallEntities 2024-04-01 2025-03-31 11217596 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 11217596 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 11217596 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 11217596 bus:FullAccounts 2024-04-01 2025-03-31 11217596 bus:OrdinaryShareClass1 2025-03-31 11217596 bus:OrdinaryShareClass1 2024-03-31 11217596 core:ComputerEquipment 2024-03-31 11217596 core:ComputerEquipment 2024-04-01 2025-03-31 11217596 core:ComputerEquipment 2025-03-31 11217596 core:CommunicationNetworkEquipment 2024-03-31
COMPANY REGISTRATION NUMBER: 11217596
Rohan Medical Services Limited
Filleted Unaudited Financial Statements
31 March 2025
Rohan Medical Services Limited
Financial Statements
Year ended 31 March 2025
Contents
Page
Statement of financial position
1
Notes to the financial statements
3
Rohan Medical Services Limited
Statement of Financial Position
31 March 2025
2025
2024
Note
£
£
£
£
Fixed assets
Tangible assets
5
31,319
42,235
Current assets
Debtors
6
28,633
36,980
Investments
7
94,854
Cash at bank and in hand
84,933
138,217
---------
---------
208,420
175,197
Creditors: amounts falling due within one year
8
20,872
21,820
---------
---------
Net current assets
187,548
153,377
---------
---------
Total assets less current liabilities
218,867
195,612
Creditors: amounts falling due after more than one year
9
4,274
12,821
Provisions
7,830
10,559
---------
---------
Net assets
206,763
172,232
---------
---------
Capital and reserves
Called up share capital
10
300
300
Profit and loss account
206,463
171,932
---------
---------
Shareholders funds
206,763
172,232
---------
---------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
Rohan Medical Services Limited
Statement of Financial Position (continued)
31 March 2025
These financial statements were approved by the board of directors and authorised for issue on 29 December 2025 , and are signed on behalf of the board by:
Dr R Yadav
Director
Company registration number: 11217596
Rohan Medical Services Limited
Notes to the Financial Statements
Year ended 31 March 2025
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 146 New London Road, Chelmsford, Essex, CM2 0AW.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable and represents amounts receivable for goods supplied and services rendered, stated net of discounts and of Value Added Tax.
Income tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Foreign currencies
Foreign currency transactions are initially recorded in the functional currency, by applying the spot exchange rate as at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are translated at the exchange rate ruling at the reporting date, with any gains or losses being taken to the profit and loss account.
Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in equity, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in equity in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in equity in respect of that asset, the excess shall be recognised in profit or loss.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Motor vehicles
-
5 years straight line
Equipment
-
3 years straight line
Finance leases and hire purchase contracts
Assets held under finance leases and hire purchase contracts are recognised in the statement of financial position as assets and liabilities at the lower of the fair value of the assets and the present value of the minimum lease payments, which is determined at the inception of the lease term. Any initial direct costs of the lease are added to the amount recognised as an asset. Lease payments are apportioned between the finance charges and reduction of the outstanding lease liability using the effective interest method. Finance charges are allocated to each period so as to produce a constant rate of interest on the remaining balance of the liability.
Financial instruments
Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as either financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
4. Employee numbers
The average number of persons employed by the company during the year amounted to 2 (2024: 2 ).
5. Tangible assets
Motor vehicles
Equipment
Total
£
£
£
Cost
At 1 April 2024
60,920
3,894
64,814
Additions
1,978
1,978
--------
-------
--------
At 31 March 2025
60,920
5,872
66,792
--------
-------
--------
Depreciation
At 1 April 2024
19,148
3,431
22,579
Charge for the year
12,184
710
12,894
--------
-------
--------
At 31 March 2025
31,332
4,141
35,473
--------
-------
--------
Carrying amount
At 31 March 2025
29,588
1,731
31,319
--------
-------
--------
At 31 March 2024
41,772
463
42,235
--------
-------
--------
Finance leases and hire purchase contracts
Included within the carrying value of tangible assets are the following amounts relating to assets held under finance leases or hire purchase agreements:
Motor vehicles
£
At 31 March 2025
29,588
--------
At 31 March 2024
41,772
--------
6. Debtors
2025
2024
£
£
Trade debtors
28,633
36,980
--------
--------
7. Investments
2025
2024
£
£
Investments
94,854
--------
----
8. Creditors: amounts falling due within one year
2025
2024
£
£
Accruals and deferred income
1,260
2,304
Corporation tax
10,500
8,332
Obligations under finance leases and hire purchase contracts
8,547
8,547
Director loan accounts
565
2,637
--------
--------
20,872
21,820
--------
--------
9. Creditors: amounts falling due after more than one year
2025
2024
£
£
Obligations under finance leases and hire purchase contracts
4,274
12,821
-------
--------
10. Called up share capital
Issued, called up and fully paid
2025
2024
No.
£
No.
£
Ordinary shares of £ 1 each
300
300
300
300
----
----
----
----
11. Related party transactions
At the balance sheet date the company owed the directors £565 (2023: 4,167) in the form of a loan account. This loan, which is shown amongst creditors, is interest free and repayable on demand.